SMAD4 and coronary artery disorder: Meanwhile, the mechanism of action of MiR-145-5p involves mitigating hypoxia/reoxygenation-induced damage to cardiac microvascular endothelial cells in coronary artery disease by inhibiting Smad4 expression [31].